Name: Nucleoside Triphosphates - From Synthesis to Biochemical Characterization (Video) | JoVE Journal
Uploaded: 2014-04-03T16:00:00.000+00:00
Duration: 15 min 22 s
Description: Learn to synthesize and characterize modified nucleoside triphosphates using a four-step one-pot procedure, reverse-phase HPLC purification, and NMR/MALDI-TOF analysis. This method enables reliable production for nucleic acid chemistry research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work was supported by the Swiss National Science Foundation (Grants n&deg; PZ00P2_126430/1 and PZ00P2_144595). Prof. C. Leumann is gratefully acknowledged for providing the lab space and equipment, as well as for his constant support. Ms. Sue Knecht is acknowledged for fruitful discussions.

1. Synthesis of the Modified Nucleoside Triphosphates
The synthetic approach chosen follows the procedure developed by Ludwig and Eckstein since this method is generally reliable and leads to very few side-products (Figure 1A)39.
<ol>
	<li>Coevaporate the suitably 3&#8217;-OAc-protected nucleoside (&#160;typically&#160;0.1 mmol) twice with anhydrous pyridine (2 ml) and then dry under vacuum overnight. At the same time, dry tributylammonium pyrophosphate (0.13 mmol) under vacuum overnight.</li>
	<li>Dissolve the nucleoside in a minimum of dry pyridine (0.2 ml) and add dry dioxane (0.4 ml) as a cosolvent. Finally, add 2-chloro-1,3,2-benzodioxaphosphorin-4-one (0.11 mmol) and allow to react at room temperature for 45 min. 
	Note: It is noteworthy that particular care should be taken with the 2-chloro-1,3,2-benzodioxaphosphorin-4-one reagent. Indeed, even storage of this reagent under an inert gas atmosphere is not sufficient to prevent its decomposition. Thus, the white solid that is formed in this decomposition can and should be scraped off prior to use.</li>
	<li>Prepare a solution of tributylammonium pyrophosphate in dry DMF (0.17 ml) and freshly distilled tributylamine (58 &#181;l; never add molecular sieves). Add the resulting solution to the reaction mixture (a white precipitate appears but quickly disappears) and allow to react at room temperature for 45 min.</li>
	<li>Prepare a solution of iodine (0.16 mmol) in pyridine (0.98 ml) and H2O (20 &#181;l) and add to the reaction mixture in order to oxidize the P&#945;(III) center. Allow the resulting dark solution to stir at room temperature for 30 min.</li>
	<li>Use a 10% aqueous solution of NaS2O3 to quench the excess I2. Remove the solvent under vacuum (the temperature of the water bath of the rotary evaporator must be kept below 30 &#176;C). Add H2O (5 ml) and allow the mixture to stand at room temperature for 30 min to hydrolyze the cyclic triphosphate moiety.</li>
	<li>At this stage, the protecting groups are usually removed (i.e. the 3&#39;-OAc and the groups on the side chains of the nucleobase). Consequently, add NH4OH (30% in H2O, 10 ml) to the crude and stir for 1.5 hr at room temperature, and remove the solvent under vacuum.</li>
	<li>Add 2 ml of H2O and split into 2 tubes. Add 12 ml of a 2% solution of NaClO4 in acetone and centrifuge (1,000 x g) for 30 min. This procedure is repeated one more time. This precipitation allows for the separation of the solvents and reagents used in the synthesis from the triphosphate (which will precipitate), thus simplifying the ensuing RP-HPLC purification substantially.</li>
	<li>After air-drying of the oily residue, record a 31P-NMR spectrum of the crude (following standard procedures, see also List of Materials and Figure 3) and dissolve in 4 ml H2O. 
	Note: This synthetic procedure mainly focuses on the generation of modified deoxynucleoside triphosphates, but a very similar procedure can be applied for their RNA counterparts (by simply using 2&#39;,3&#39;-bis-O-acetylated precursors).</li>
</ol>
2. HPLC Purification of the Modified Nucleoside Triphosphates
<ol>
	<li>Preparation of a 1 M stock solution of triethylammonium bicarbonate (TEAB):40
	<ol>
		<li>Prepare a solution of 1 mole of triethylamine (139 ml) in &#8776; 600 ml of distilled and filtered H2O.</li>
		<li>Bubble CO2 (via dry ice and a gas bubbler) into the solution under vigorous stirring until a pH of 7.6 is reached (this will take at least 10 hr). This stock solution can be stored in the fridge for up to one month.</li>
	</ol>
	</li>
	<li>Purification:
	<ol>
		<li>Prepare two buffer solutions from the 1 M stock: 2 L of 50 mM TEAB in ultrapure water (eluent A) and 1 L of 50 mM TEAB in 50% MeCN (eluent B). Degas both eluents under vacuum and stirring for 20 min (careful attention is required so as not to alter the pH by removing CO2 during degassing).</li>
		<li>Prepare an analytical sample by dissolving 10 &#181;l of the crude triphosphate in 300 &#181;l distilled H2O and inject into an HPLC system equipped with a semi-preparative RP column (C18) and using a gradient ranging from 0-100% B in 40 min (Figure 4). Adjust the HPLC program according to the Rt of the triphosphate (which is usually the main peak on the chromatogram) and the diphosphate (which has a slightly lower Rt). Purify the crude mixture using these conditions and by removing early fractions that might contain some diphosphate.</li>
		<li>Combine all the fractions that contain the product and freeze-dry (which is preferred to evaporation on the rotary evaporator in order to minimize hydrolysis to the undesired diphosphate). Coevaporate several times with ultrapure water (to remove remnant triethylamine from the eluents). Assess the purity of the triphosphate by NMR (both 1H and 31P NMR) and MALDI-TOF by application of standard protocols (see Figure 5). Typical yields obtained by application of this protocol typically lie in the range of 30-70%, depending on the substrate.</li>
	</ol>
	</li>
</ol>
3. Primer Extension Reactions and TdT Polymerization
<ol>
	<li>5&#39;-end labeling of the primer
	<ol>
		<li>Mix 30 pmol of the appropriate primer (e.g. P1, List of Materials) with 4 &#181;l of 10x Polynucleotide kinase (PNK) buffer, 3 &#181;l of &#947;-[32P]-ATP, 1 &#181;l of PNK, and ddH2O (for a total reaction volume of 40 &#181;l). Incubate the reaction mixture at 37 &#176;C for 30 min and then heat-deactivate the kinase (10 min at 70 &#176;C).</li>
		<li>During the labeling reaction prepare a G10 Sephadex column by plugging a 1 ml pipette tip with silanized glass wool and filling the tip with G10 solution (10% in ddH2O, autoclaved). Spin down and wash three times with 500 &#181;l ddH2O and one final wash with 50 &#181;l ddH2O. Run the reaction mixture through the G10 (to remove the free radioactive label).</li>
		<li>Gel purify (PAGE 20%) the radiolabeled primer and recover by application of the crush and soak method (i.e. elution with 500 &#181;l of an aqueous solution containing 1% LiClO4 and 1 mM NEt3 (pH 8) at 72 &#176;C for 15 min). Ethanol precipitate and G10 desalt the eluted oligonucleotide.</li>
	</ol>
	</li>
	<li>Primer extension reaction
	<ol>
		<li>Anneal 1 pmol of radiolabeled primer P1, 10 pmol primer P1, and 10 pmol of template T1 (List of Materials) in 10x reaction buffer (provided by the supplier of the polymerase to be used) by placing the tube in hot (90-95 &#176;C) water and by allowing to gradually cool down to room temperature (over 45 min).</li>
		<li>Put the tube on ice and add (in turn) the dNTP cocktail (containing both the modified and the natural triphosphates, 100 &#181;M final concentration) and 1 U of the DNA polymerase (Vent (exo-), Klenow, Pwo or 9&#176;Nm) and complete with water (for a total reaction volume of 20 &#181;l). Incubate at the optimal working temperature of the enzyme (e.g. 60 &#176;C for 30 min when Vent (exo-) is being used).</li>
		<li>Add 20 &#181;l of stop solution (formamide (70%), ethylenediaminetetraacetic acid (EDTA; 50 mM), bromophenol blue (0.1%), xylene cyanol (0.1 %)), heat the samples (95 &#176;C, 5 min), cool down (0 &#176;C), and resolve by denaturing polyacrylamide gel electrophoresis. Visualize by phosphorimager.</li>
	</ol>
	</li>
	<li>TdT polymerization
	<ol>
		<li>Dilute 7 pmol of single-stranded, unlabeled primer P2 (List of Materials), 1 pmol of radiolabeled primer in 1 &#181;l TdT buffer 10x.</li>
		<li>Put the tube on ice and add (in turn) the dNTP cocktail (at an adequate concentration comprised between 10 and 200 &#181;M) and the TdT polymerase (4 U). Incubate at 37 &#176;C for 1 hr. Add 10 &#181;l of the stop solution, heat the samples (95 &#176;C, 5 min), cool down (0 &#176;C), and resolve by denaturing polyacrylamide gel electrophoresis (PAGE 15%). Visualize by phosphorimager.</li>
	</ol>
	</li>
</ol>
4. PCR with Modified Nucleoside Triphosphates
<ol>
	<li>Mix 8 pmol of both the forward and reverse primers with 0.5 pmol of the template to be amplified. Add 10x reaction buffer and the dNTP cocktail (for a 200 &#181;M final concentration) and put the tube on ice. Add 1 U of the DNA polymerase and complete with H2O to reach a final volume of 20 &#181;l. Transfer the mixture into a PCR vial and carry out 30 PCR cycles.</li>
	<li>Dilute 6 &#181;l with 6 &#181;l of 2x sucrose loading buffer and resolve by agarose 2% (stained with ethidium bromide) electrophoresis. Visualize by phosphorimager.</li>
</ol>

No conflicts of interest declared.

The inclusion of modifications into nucleic acids is of interest for numerous practical applications including the development of antisense and antigene agents42,43, labeling and functional tagging of oligonucleotides41, and in efforts to expand the genetic alphabet44-46. Chemical alterations and functional groups are usually introduced into nucleic acids by application of standard and automated solid-phase synthesis protocols. However, the phosphoramidite building blocks need to be resil...

5&#39;-Nucleoside triphosphates ((d)NTPs) represent a class of vital biomolecules that are involved in countless processes and functions ranging from being the universal currency of energy to regulators of cell metabolism. In addition to their role in these fundamental biological transformations, their modified counterparts have advanced as a versatile and mild platform for the introduction of functional groups into oligonucleotides, a methodology that nicely complements the automated solid-phase synthesis that is usually applied1,2. Indeed, provided the (d)NTPs can act as substrates for RNA and DNA polymerases3, a wealth of functional groups including amino acids4-13, boronic acids14,15, nornbornene16, diamondoid-like residues17, side-chains for organocatalysis18, bile acids19, and even oligonucleotides20 can be introduced into oligonucleotides.
Beyond representing a convenient vector for the functionalization of nucleic acids, modified dNTPs can be engaged in SELEX and other related combinatorial methods of in vitro selection for the generation of modified catalytic nucleic acids21-30 and aptamers for various practical applications10,31-36. The additional side-chains that are introduced by the polymerization of the modified dNTPs are thought to increase the chemical space that can be explored during a selection experiment and supplement the rather poor functional arsenal of nucleic acids37. However, despite these attractive traits and the recent progress made in the development of both synthetic and analytical methods, no universally applicable and high-yielding procedure exists for the crafting of modified nucleoside triphosphates2,38.
The aim of this present protocol is to shed light into the (sometimes) intricate procedures leading to the synthesis and biochemical characterization of these activated building blocks (Figure 1B). Special emphasis will be given on all the synthetic details that often are difficult to find or are absent in experimental sections but are yet crucial for the successful completion of the synthetic pathway leading to the isolation of pure (d)NTPs (Figure 1).

<table><tbody><tr><td>Tributylammonium pyrophosphate&amp;nbsp;</td><td>Sigma Aldrich</td><td>P8533</td><td>Hygroscopic solid, keep under Ar</td></tr><tr><td>2-Chloro-1,3,2-benzodioxaphosphorin-4-one&amp;nbsp;</td><td>Sigma Aldrich</td><td>324124</td><td>Moisture sensitive</td></tr><tr><td>Pyridine</td><td>Sigma Aldrich</td><td>82704</td><td>Under molecular sieves</td></tr><tr><td>Dioxane</td><td>Sigma Aldrich</td><td>296309</td><td>Under molecular sieves</td></tr><tr><td>Dimethylformamide (DMF)</td><td>Sigma Aldrich</td><td>40248</td><td>Under molecular sieves</td></tr><tr><td>Acetonitrile&amp;nbsp;</td><td>Fisher Scientific</td><td></td><td>HPLC grade</td></tr><tr><td>Triethylamine</td><td>Sigma Aldrich</td><td>90342</td><td></td></tr><tr><td>Tributylamine</td><td>Sigma Aldrich</td><td>90781</td><td></td></tr><tr><td>ddH&lt;sub&gt;2&lt;/sub&gt;O</td><td>Milli-Q</td><td></td><td>deionized and purified water, autoclaved in the presence of Diethylpyrocarbonate (DEPC)</td></tr><tr><td>Diethylpyrocarbonate (DEPC)</td><td>Sigma Aldrich</td><td>159220</td><td></td></tr><tr><td>D&lt;sub&gt;2&lt;/sub&gt;O</td><td>Cambridge Isotope Laboratories, Inc.</td><td>DLM-4-25</td><td></td></tr><tr><td>&amp;#947;-[&lt;sup&gt;32&lt;/sup&gt;P]-ATP</td><td>Hartmann Analytics</td><td>FP-301</td><td></td></tr><tr><td>Natural dNTPs</td><td>Promega</td><td>U1420</td><td></td></tr><tr><td>Vent (exo&lt;sup&gt;-&lt;/sup&gt;) DNA polymerase</td><td>NEB</td><td>M0257S</td><td></td></tr><tr><td>DNA polymerase I, Large (Klenow) Fragment</td><td>NEB</td><td>MO210S</td><td></td></tr><tr><td>9&amp;deg;&lt;em&gt;N&lt;sub&gt;m&lt;/sub&gt;&lt;/em&gt; DNA polymerase</td><td>NEB</td><td>MO260S</td><td></td></tr><tr><td>Terminal deoxynucleotidyl Transferase (TdT)</td><td>Promega</td><td>M828A</td><td></td></tr><tr><td>Pwo DNA polymerase</td><td>Peqlab</td><td>01 01 5010</td><td></td></tr><tr><td>T4 PNK</td><td>Thermo Scientific</td><td>EK0032</td><td></td></tr><tr><td>Acrylamide/bisacrylamide (19:1, 40%)</td><td>Serva</td><td>10679.01</td><td></td></tr><tr><td>Agarose</td><td>Apollo Scientific</td><td>BIA1177</td><td></td></tr><tr><td>G10 Sephadex</td><td>Sigma</td><td>G10120</td><td></td></tr><tr><td>Urea</td><td>Apollo Scientific</td><td>BIU4110</td><td></td></tr><tr><td>Jupiter semipreparative RP-HPLC column (5&amp;#956; C18 300 &amp;Aring;)</td><td>Phenomenex</td><td></td><td></td></tr><tr><td>Gene Q Thermal Cycler</td><td>Bioconcept</td><td>BYQ6042E</td><td></td></tr><tr><td>PCR vials</td><td>Bioconcept</td><td>3220-00</td><td></td></tr><tr><td>HPLC system</td><td>Amersham Pharmacia Biotech</td><td></td><td>&amp;Auml;kta basic 10/100</td></tr><tr><td>All oligonucleotides were purchased from Microsynth and purified by PAGE</td><td></td><td></td><td></td></tr><tr><td>5&amp;#039;-CAAGGACAAAATAC&lt;br /&gt;
CTGTATTCCTT &lt;strong&gt;P1&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>5&amp;#039;-GACATCATGAGAGA&lt;br /&gt;
CATCGCCTCTGGGCTA&lt;br /&gt;
ATAGGACTACTTCTAAT&lt;br /&gt;
CTGTAAGAGCAGATCC&lt;br /&gt;
CTGGACAGGCAAGGAA&lt;br /&gt;
TACAGGTATTTTGTCCTTG &lt;strong&gt;T1&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>5&amp;#039;-GAATTCGATATCAAG &lt;strong&gt;P2&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td colspan="4">More information on experimental procedures and equipment can be found in the following articles:&lt;br /&gt;
&lt;em&gt;Chem. Eur. J.&lt;/em&gt; &lt;strong&gt;2012&lt;/strong&gt;, 18, 13320-13330&lt;br /&gt;
&lt;em&gt;Org. Biomol. Chem.&lt;/em&gt; &lt;strong&gt;2013&lt;/strong&gt;, DOI: 10.1039/C3OB40842F</td></tr></tbody></table>

nucleoside triphosphates - from synthesis to biochemical characterization

Nucleoside Triphosphates - From Synthesis to Biochemical Characterization

The traditional strategy for the introduction of chemical functionalities is the use of solid-phase synthesis by appending suitably modified phosphoramidite precursors to the nascent chain. However, the conditions used during the synthesis and the restriction to rather short sequences hamper the applicability of this methodology. On the other hand, modified nucleoside triphosphates are activated building blocks that have been employed for the mild introduction of numerous functional groups into nucleic acids, a strategy that paves the way for the use of modified nucleic acids in a wide-ranging palette of practical applications such as functional tagging and generation of ribozymes and DNAzymes. One of the major challenges resides in the intricacy of the methodology leading to the isolation and characterization of these nucleoside analogues.
	
	In this video article, we present a detailed protocol for the synthesis of these modified analogues using phosphorous(III)-based reagents. In addition, the procedure for their biochemical characterization is divulged, with a special emphasis on primer extension reactions and TdT tailing polymerization. This detailed protocol will be of use for the crafting of modified dNTPs and their further use in chemical biology.

Modified nucleoside triphosphates are alluring synthetic targets since they allow for the facile introduction of an vast array of functional groups into nucleic acids41. However, the isolation and characterization of these activated building blocks is often revealed to be arduous. Consequently, the results shown herein are thought to provide a helping hand to follow the various steps within the aforementioned synthetic and biochemical procedures (Figure 1B).
In part...

The protocol described herein aims to explain and abridge the numerous obstacles in the way of the intricate route leading to modified nucleoside triphosphates. Consequently, this protocol facilitates both the synthesis of these activated building-blocks and their availability for practical applications.

The  traditional strategy for the introduction of chemical functionalities is the  use of solid-phase synthesis by appending suitably modified ...

The overall goal of this video is to demonstrate the procedure from synthesis of the modified nucleoside phosphates to their complete biochemical characterization. This is accomplished by first converting the suitably protected nucleoside precursor to the corresponding tri phosphate by application of a four step one pot procedure. The second step is to purify the resulting tri phosphate first by a precipitation and then by reverse phase high performance liquid chromatography.Next, the tri phosphate analog is characterized by nuclear magnetic resonance and matrix assisted laser DESORPTION ionization time of flight or NMR and maloff to ensure high purity. The final step is primer extension reactions and terminal deoxy nucleotide transferase or TDT polymerization reactions. Ultimately, the reaction products, and thus the substrate acceptance of the tri phosphate are analyzed by gel electrophoresis.The advantage of this method compared to other synthetic strategies like the Borge approach, is that fewer side products are being formed, and thus the purification is easier. Generally, individuals new to this technique will struggle as it is quite a lengthy and intricate procedure that requires knowledge in multiple fields. We first had the idea for this method to be filmed when we synthesized modified phosphates and found it rather challenging to find a detailed procedure.Another advantage of this method is that it can be used to tackle other questions in the field of modified nucleic acids. Indeed, it can be used to select for DNA enzymes that catalyze a broad range of reactions. In addition, this method can be used for the functional tagging of nucleic acids.Visual demonstration of this method is critical as synthesis and purification steps are difficult to learn because tri phosphates are polar and activated derivatives that must be handled with care. To begin co evaporate the suitably three-prime hydroxyl protected nucleoside twice with two milliliters of anhydrous purine before drying under vacuum overnight. At the same time, dry tribunal ammonium pyrophosphate under vacuum overnight the following day dissolved the nucleoside in a minimum of 200 microliters of dry pyridine.Then add 400 microliters of dry dioxane as a COS solvent. Finally, add the cyclic phosphorus three derivative and allow it to react at room temperature for 45 minutes. Next, prepare a solution of dry butyl ammonium pyrophosphate in 170 microliters of dry dimethylformamide and 58 microliters of freshly distilled tri butyl amine.Add the resulting solution to the reaction mixture and allow it to react at room temperature for 45 minutes. Then prepare a solution of 160 micromolar iodine in 980 microliters of purine and 20 microliters of water. Add the solution to the reaction mixture.In order to oxidize the alpha phosphorus center. Allow the resulting dark solution to stir at room temperature for 30 minutes. Use a 10%aqueous solution of sodium thio sulfate to quench the excess iodine.Remove the solvent under vacuum. Then add five milliliters of water and allow the mixture to stand at room temperature for 30 minutes to hydrolyze the cyclic tri phosphate moty. At this stage, the protecting groups are usually removed.Consequently, add 30%Imodium hydroxide to the crude sample. Stir for 1.5 hours at room temperature before removing the solvent under vacuum. Next, add two milliliters of water and split the mixture into tube tubes.Add 12 milliliters of a 2%solution of sodium per chlorate in acetone and centrifuge for 30 minutes before repeating the procedure. One more time. The reagents used in the synthesis from the tri phosphate will precipitate forming an oily residue and allowing for the separation of the solvents, and thus simplifying the ensuing reverse phase HPLC purification substantially after air drying of the oily residue.Record a P 31 NMR spectrum of the crude sample according to standard procedures. Following NMR dissolved the oily residue in four milliliters of distilled water. Begin HPLC purification with preparation of 50 millimolar triethyl ammonium bicarbonate in ultrapure water as EENT A and in 50%acetyl nitrile as eent B as detailed in the text protocol, Degas both EENT under vacuum and stirring for 20 minutes.Prepare an analytical sample by dissolving 10 microliters of the crude tri phosphate in 300 microliters of distilled water. Then using a gradient ranging from 0%B to 100%B in 40 minutes. Inject the sample into an HPLC system equipped with a semi preparative reverse Phase C 18 column.Adjust the HPLC program according to the retention time of the tri phosphate and the diphosphate. Purify the crude mixture using these conditions and by removing early fractions that might contain some diphosphate, combine all the fractions that contain the product and freeze dry. Then co evaporate several times with ultrapure water.Assess the purity of the tri phosphate by NMR and maloff by application of standard protocols. Typical yields obtained by application of this protocol lie in the range of 30 to 70%depending on the substrate for five prime and labeling of the primer. Mix the primer and reagents as detailed in the text protocol and incubate the labeling reaction at 37 degrees Celsius for 30 minutes.During the labeling reaction, prepare a G 10 cidex column by plugging a one milliliter pipette tip with siloized glass wool and filling the tip with G 10 solution. Spin down and wash three times with 500 microliters of double distilled water and one final wash with 50 microliters of double distilled water. Following incubation of the labeling reaction, heat deactivate the kinase for 10 minutes at 70 degrees Celsius.Next, run the reaction mixture through the G 10. To remove the free radioactive label gel, purify the radio labeled primer and recover by application of the crush and soak method, ethanol precipitate and G 10 desalt the eluded oligonucleotide. For the primer extension reaction, combine one PICA mole of radiolabeled primer, P one 10 PICA moles of primer, P one and 10 PICA moles of template, T one in 10 x reaction buffer and kneel in hot water.Then gradually cool down to room temperature over 45 minutes. Put the tube on ice and add the nucleoside phosphate or DNTP cocktail and one unit of the DNA polymerase ice. Complete the reaction with water for a total volume of 20 microliters incubate at the optimal working temperature of the enzyme.Then add 20 microliters of stop solution and heat the samples at 95 degrees Celsius for five minutes. Cool, the samples down at zero degrees Celsius. Before resolving by denaturing poly acrylamide gel electrophoresis.Visualize the bands by phospho imager for TDT polymerization, dilute single stranded unlabeled primer P two and radio labeled primer in one microliter of TDT buffer. Put the tube on ice and add the DNTP cocktail and the TDT polymerase then incubate at 37 degrees Celsius for one hour. Following incubation, add 10 microliters of the stop solution before heating the samples at 95 degrees Celsius for five minutes, and then cooling down at zero degrees Celsius.After resolving the sample by denaturing poly acrylamide gel electrophoresis, visualize the bands using a phospho imager. Shown here is a typical crude P 31 NMR spectrum of a modified DNTP where the characteristic signals of the phosphorus centers can be observed. In addition, signals stemming from the diphosphate and monophosphate side.Products along with higher phosphates are always observed at this stage. Reverse phase HPLC analysis of the crude mixture is shown here. The main peak corresponds to the five prime phosphate, while the main byproduct, the five prime diphosphate displays a slightly lower retention time.Finally, after a thorough reverse phase, HPLC purification, the modified DNTP is characterized by NMR and maldi to shown here is the maloff spectrum of the sulfa ide, modified DUTP analog. The sodium adduct can be seen at mass overcharge of 712.54, and no trace of diphosphate is present. Both the P 31 NMR and proton NMR spectra are crucial for assessing the purity of the modified dps.Since the presence of undesired dye and mono phosphates gives distinctive signals illustrated, here is the outcome of primary extension reactions with trans proline modified DUTP histamine modified DATP and valeric acid modified DCTP used either as lone modifications as combinations of two modified DN dps or together, along with a lone natural DGTP. Finally, representative TDT mediated polymerization reactions with different modified DUTP analogs were analyzed with denaturing poly acrylamide gel electrophoresis. In this context, cis proline modified DUTP and peptide modified DUTP are the best substrates for TDT.Since the tailing efficiencies are comparable or exceed those of the natural DTTP instead, urea modified DUTP is a rather poor substrate in this context. Since little poly disperse, longer sized oligonucleotides can be observed Once mastered, this technique can be done in about one week if it is performed properly. While attempting this procedure, it is important to keep in mind that nuclear cytric phosphates are nature's activated building blocks, and therefore care should be taken while handling them After it was created.Researchers in the field of nucleic acids use this method to explore combinatorial selections to generate modified abers and catalytic nucleic acids. After watching this video, you should have a good understanding of how to synthesize and characterize modified phosphates using the four step one pop procedure, followed by reverse phase HPLC purification and primary extension reactions. Some experimental details that are not normally found in experimental sections will become apparent.This method can be used in combination with other techniques such as PCR to answer additional questions. Indeed, it can be used to assess the compatibility of modified tri phosphates with methods of in VIO selection.

nucleoside-triphosphates-from-synthesis-to-biochemical

Research

JoVE Journal

Chemistry

This article provides a detailed procedure on the solid-phase synthesis, purification, and characterization of dodecamers of RNA modified at the C2'-O-position. UV-vis and circular dichroism photometric analyses are used to quantify and characterize structural aspects, i.e., single-strands or double-strands.

Protocol for the Solid-phase Synthesis of Oligomers of RNA Containing a 2'-O-thiophenylmethyl Modification and Characterization via Circular Dichroism

Here, we present protocols for the synthesis of disaccharide nucleosides by the regioselective O-glycosylation of ribonucleosides via a temporary protection of their 2',3'-diol moieties utilizing a cyclic boronic ester. This method applies to several unprotected nucleosides such as adenosine, guanosine, cytidine, uridine, 5-methyluridine, and 5-fluorouridine to give corresponding disaccharide nucleosides.

Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

NMR-based activity assays have been developed to identify and characterize inhibitors of two nucleoside ribohydrolase enzymes. Protocols are provided for initial compound assays at 500 μM and 250 μM, dose-response assays for determining IC50 values, detergent counter screen assays, jump-dilution counter screen assays, and assays in E. coli whole cells.

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases

A precise and reproducible method for in vivo nucleosides/nucleotides quantification in plants is described here. This method employs an HPLC-MS/MS.

Plant Sample Preparation for Nucleoside/Nucleotide Content Measurement with An HPLC-MS/MS

Oligonucleotide 5′-triphosphates are ubiquitous components in essential biological pathways and have seen increasing use in biotechnology applications. Here, we describe techniques for the routine synthesis and purification of oligonucleotide 5′-triphosphates, starting from oligonucleotides prepared by standard automated synthesis techniques.

Chemical Triphosphorylation of Oligonucleotides

Isolation and characterization of the lipid A domain of lipopolysaccharide (LPS) from gram-negative bacteria provides insight into cell surface based mechanisms of antibiotic resistance, bacterial survival and fitness, and how chemically diverse lipid A molecular species differentially modulate host innate immune responses.

Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria

Peptide tertiary amides (PTAs) are a superfamily of peptidomimetics that include but are not limited to peptides, peptoids and N-methylated peptides. Here we describe a synthetic method which combines both split-and-pool and sub-monomer strategies to synthesize a one-bead one-compound library of PTAs.

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Synthesis, activation, and characterization of intentionally designed metal-organic framework materials is challenging, especially when building blocks are incompatible or unwanted polymorphs are thermodynamically favored over desired forms. We describe how applications of solvent-assisted linker exchange, powder X-ray diffraction in capillaries and activation via supercritical CO2 drying, can address some of these challenges.

Synthesis and Characterization of Functionalized Metal-organic Frameworks

The goal of this manuscript is to demonstrate a straightforward method for the preparation of ynones from acyl chloride and potassium alkynyltrifluoroborate salt starting materials. The one-pot reaction proceeds rapidly in the presence of boron trichloride without exclusion of air and moisture.

Metal-free Synthesis of Ynones from Acyl Chlorides and Potassium Alkynyltrifluoroborate Salts

Ruthenium phosphine complexes are widely used for homogeneous catalytic reactions such as hydrogenations. The synthesis of a series of novel tridentate ruthenium complexes bearing the N-triphos ligand N(CH2PPh2)3 is reported. Additionally, the stoichiometric reaction of a dihydride Ru–N-triphos complex with levulinic acid is described.

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Learn to synthesize and characterize modified nucleoside triphosphates using a four-step one-pot procedure, reverse-phase HPLC purification, and NMR/MALDI-TOF analysis. This method enables reliable production for nucleic acid chemistry research.

Nucleoside Triphosphates - From Synthesis to Biochemical Characterization

Explore More Videos